Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Paul

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Cancers|December 11, 2022
Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null MiceSebastian Knitter, Gregor Duwe, Anika Sophie Beierle, et al.
Cancer Letters|June 10, 2022
Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencingJoao M Alves, Sonia Prado-López, Laura Tomás, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2016
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinomaStephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
The Journal of Clinical Investigation|April 3, 2008
A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapyAnja Fritsch, Stefan Loeckermann, Johannes S Kern, et al.
Cancer Medicine|July 27, 2023
Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinomaIsabella Lurje, Deniz Uluk, Sandra Pavicevic, et al.
International Journal of Cancer|December 23, 2014
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsChristoph Schulz, Frank Kullmann, Volker Kunzmann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Cells|January 10, 2025
Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer PatientsPhillip Schiele, Stefan Kolling, Stanislav Rosnev, et al.
BMC Cancer|August 25, 2011
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trialClemens Giessen, Ludwig Fischer von Weikersthal, Axel Hinke, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 13, 2016
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancerStephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancers|December 11, 2022
Inhibition of Vascular Endothelial Growth Factor Protects against the Development of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome in Wild-Type but Not in CD39-Null MiceSebastian Knitter, Gregor Duwe, Anika Sophie Beierle, et al.
Cancer Letters|June 10, 2022
Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencingJoao M Alves, Sonia Prado-López, Laura Tomás, et al.
Journal of Cancer Research and Clinical Oncology|September 16, 2016
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinomaStephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
The Journal of Clinical Investigation|April 3, 2008
A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapyAnja Fritsch, Stefan Loeckermann, Johannes S Kern, et al.
Cancer Medicine|July 27, 2023
Body composition is associated with disease aetiology and prognosis in patients undergoing resection of intrahepatic cholangiocarcinomaIsabella Lurje, Deniz Uluk, Sandra Pavicevic, et al.
International Journal of Cancer|December 23, 2014
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsChristoph Schulz, Frank Kullmann, Volker Kunzmann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Cells|January 10, 2025
Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer PatientsPhillip Schiele, Stefan Kolling, Stanislav Rosnev, et al.
BMC Cancer|August 25, 2011
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trialClemens Giessen, Ludwig Fischer von Weikersthal, Axel Hinke, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 13, 2016
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancerStephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
Pageof 10